David Bourdon, Chief Executive Officer and Director of LifeStance Health Group, Inc., filed a Form 4 on September 4, 2026, reporting the transfer of 150,000 shares of common stock to a family member for no value on September 2, 2026.
Director Stanley Tang filed a Form 4 with the SEC on September 4, 2026, reporting the conversion and sale of DoorDash, Inc. (NASDAQ:DASH) Class A Common Stock on September 2, 2026, pursuant to a Rule 10b5-1 trading plan.
Nicholas Caezza, Deputy General Counsel of Butterfly Network, Inc., filed a Form 4 on September 4, 2026, disclosing the sale of 1,709 shares of Class A Common Stock on September 2, 2026, pursuant to the company's sell-to-cover policy for tax withholding obligations.
A Form 4 filed with the SEC on September 4, 2026, discloses that Christopher D. Brown, a director of 908 Devices Inc. (NASDAQ:MASS), sold 30,000 shares of common stock on September 2, 2026, under a pre-established Rule 10b5-1 trading plan.
Raymond Whittaker, a director of Consolidated Water Co. Ltd. (NASDAQ:CWCO), filed a Form 4 on September 4, 2026, disclosing the sale of 1,000 shares of common stock on September 3, 2026.
Kevin Michael O'Neill, CEO of PDx at GE HealthCare Technologies Inc. (NASDAQ:GEHC), filed a Form 4 on September 4, 2026, disclosing that 718 shares of common stock were withheld on September 3, 2026, to cover tax obligations tied to the vesting of restricted stock …
George A. Newcomb, Chief Accounting Officer of GE HealthCare Technologies Inc., filed a Form 4 on September 4, 2026, reporting the withholding of 112 shares of common stock on September 3, 2026, to satisfy tax obligations connected to the vesting of restricted stock units.
Minchung Kgil, Chief Financial Officer of Figure Technology Solutions, Inc., filed a statement of changes in beneficial ownership on September 4, 2026, reporting a transaction dated September 2, 2026, involving Class A Common Stock.
Philip Rackliffe, CEO of AIS at GE HealthCare Technologies Inc., filed a Form 4 on September 4, 2026, reporting the withholding of 798 shares of common stock on September 3, 2026, to satisfy tax obligations connected to the vesting of restricted stock units.
A Statement of Changes in Beneficial Ownership was filed on September 4, 2026, reporting that John Welch, a director of Greenlight Capital Re, Ltd. (NASDAQ:GLRE), received a restricted stock award of ordinary shares on September 3, 2026.